Speakers
Anton Illsley
Jim Pierrepont
James Naylor
Darren Wilson
Podium Lecture
Anton Illsley EMEA Business Development Director Robotics for MicroPort.
I have worked in the Orthopaedic industry for 17 years starting in 2006 as a sales rep for Biomet then moving to Depuy Synthes in 2012 performing roles in sales management and marketing, before making the move in 2017 to Stryker to work with Orthopaedic Robots with Mako. Focusing on EMEA markets for business development in Mako helping to grow and shape a robotics market in Orthopaedics, before moving to managing strategic focused initiatives on data analytics projects and patient wearable technology. This was where my passion for technology and innovation evolved for supporting adoption of these innovative technologies across multiple markets. Building that skill set which then led me to a leadership role in Microport in 2024 with a focus on developing the SkyWalker Orthopaedic robot for use with the Evolution medial pivot knee, with a focus to become one of the next generation orthopaedic robotics platforms providing innovative technology and data collection to support surgeons to develop their skills in robotics and improve the outcomes for the patients that they treat
James Naylor is a Senior Marketing Manager for Johnson & Johnson MedTech and works across digital technology and Hips. James has been in Orthopaedics as part of Sales or Marketing for more than 20 years starting as a sales rep and moving through to his current role as a Strategic Marketer for the Global Group. In his current role James is responsible for the management and delivery of digital projects within Hips and owns the future roadmaps for digital technology Globally for Hips. James’ role involves sourcing companies and products that fit the roadmaps and onboarding those companies as valued partners.
Michael has worked in the medical device industry for 25 years in research and development and scientific marketing roles, with a focus on procedural technology for joint replacement. Recently, Michael has pioneered the application of contemporary Science Communication (SciComm) principles with a special interest in communicating between high science-capital audiences. Additionally, Michael remains focused on academic work, specifically on acceptance and understanding of AI amongst orthopaedic surgeons.